← DrugApprovals
HomeDrug Approvals

LAMISIL AT (TERBINAFINE) — FDA Approval NDA021958 (KARO HLTHCARE)

LAMISIL AT (TERBINAFINE) — FDA Approval NDA021958 (KARO HLTHCARE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LAMISIL AT; Active ingredients: TERBINAFINE; Application number: NDA021958.

Brand nameLAMISIL AT
Active ingredientsTERBINAFINE
Application numberNDA021958
SponsorKARO HLTHCARE
Dosage formGEL
RouteTOPICAL
Marketing statusOver-the-counter
Products in application1
First approval date20060724
SourceopenFDA Drugs@FDA

🔍 Search all drug approvals →